Avista Capital Partners has acquired Taconic Biosciences, a provider of genetically engineered research models (GEMs), as it reaches its 70th anniversary. Taconic specialises in genetically engineered research models and services, specifically murine models for use in drug discovery research and non-clinical safety testing. The company has reassured customers that there will be no interruption or […]
